Unicycive Therapeutics, Inc. (UNCY) Ownership
UNCY ownership summary
as of October 18, 2026- Institutions
- 42.5% of shares outstanding
- Insiders
- 2.26% of shares outstanding
- Shares outstanding
- 27.4M
- Float
- 27.2M shares available to trade
- Short interest
- 17.83% 4.9M shares short
- Days to cover
- 5.57 short interest up 15.5% vs prior month
- Institutions 42.49%
- Insiders 2.26%
- Other investors 55.25%
UNCY top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | 10.06% | 2.8M | $9.4M | +1.9M (+198.4%) | June 30, 2026 |
| 2 | BlackRock Inc | 5.07% | 1.4M | $4.7M | +1.4M (+3,836.7%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 3.85% | 1.1M | $3.6M | +260,051 (+32.0%) | June 30, 2026 |
| 4 | Octagon Capital Advisors LP | 3.59% | 1.0M | $3.4M | — | June 30, 2026 |
| 5 | Geode Capital Management, LLC | 2.02% | 564K | $1.9M | +360,275 (+176.8%) | June 30, 2026 |
| 6 | Vivo Capital, LLC | 1.97% | 550K | $1.8M | −1.2M (−69.3%) | June 30, 2026 |
| 7 | Marshall Wace Asset Management Ltd | 1.97% | 548K | $1.8M | +392,924 (+253.6%) | June 30, 2026 |
| 8 | Logos Global Management LP | 1.70% | 474K | $1.6M | — | June 30, 2026 |
| 9 | State Street Corp | 1.62% | 450K | $1.5M | +370,135 (+462.5%) | June 30, 2026 |
| 10 | Diametric Capital, LP | 1.34% | 374K | $1.3M | +293,770 (+365.6%) | June 30, 2026 |
| 11 | J. Goldman & Co LP | 1.18% | 327K | $1.1M | +327,345 (0.0%) | June 30, 2026 |
| 12 | Diadema Partners LP | 1.09% | 304K | $1.0M | +197,593 (+186.3%) | June 30, 2026 |
| 13 | Millennium Management LLC | 0.97% | 271K | $912,092 | −1.1M (−80.6%) | June 30, 2026 |
| 14 | Dauntless Investment Group, LLC | 0.77% | 214K | $719,040 | +66,913 (+45.5%) | June 30, 2026 |
| 15 | Citigroup Inc | 0.66% | 183K | $613,717 | +182,653 (+18,265,300.0%) | June 30, 2026 |
| 16 | Northern Trust Corp | 0.65% | 182K | $611,285 | +145,993 (+406.2%) | June 30, 2026 |
| 17 | Vanguard Portfolio Management, LLC | 0.61% | 169K | $568,499 | +169,196 (0.0%) | June 30, 2026 |
| 18 | Susquehanna International Group, LLP | 0.57% | 160K | $537,731 | −39,180 (−19.7%) | June 30, 2026 |
| 19 | Jump Financial LLC | 0.55% | 153K | $514,080 | +153,000 (0.0%) | June 30, 2026 |
| 20 | Vanguard Fiduciary Trust Co | 0.53% | 149K | $500,522 | +47,891 (+47.4%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 15 holders added 6.2M shares and 3 cut 2.4M.
UNCY top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.89% | 806K | $2.7M | — | August 31, 2026 |
| 2 | iShares Russell 2000 ETF | 2.22% | 619K | $2.1M | −7,168 (−1.1%) | September 30, 2026 |
| 3 | Fidelity Small Cap Index | 0.97% | 269K | $903,329 | +1,703 (+0.6%) | July 31, 2026 |
| 4 | iShares Russell 2000 Growth ETF | 0.73% | 204K | $683,928 | −258 (−0.1%) | September 30, 2026 |
| 5 | PPF Helix Biotechnology I USD | 0.57% | 160K | $537,600 | — | June 30, 2026 |
| 6 | Vanguard Russell 2000 ETF | 0.51% | 141K | $475,168 | +902 (+0.6%) | September 30, 2026 |
| 7 | Fidelity Extended Market Index | 0.40% | 111K | $371,293 | +4,763 (+4.5%) | August 31, 2026 |
| 8 | iShares Micro-Cap ETF | 0.28% | 78K | $262,762 | −539 (−0.7%) | September 30, 2026 |
| 9 | Dimensional US Small Cap ETF | 0.24% | 68K | $227,899 | — | September 30, 2026 |
| 10 | Schwab Small Cap Index | 0.22% | 63K | $210,148 | +7,702 (+14.0%) | August 31, 2026 |
| 11 | Stt Strt SPDR® Russell2000 US SmCapETF | 0.22% | 62K | $209,829 | −4,351 (−6.5%) | September 30, 2026 |
| 12 | iShares Russell 2000 Small-Cap Idx Instl | 0.16% | 46K | $153,468 | — | August 31, 2026 |
| 13 | Goldman Sachs ActiveBeta® US SmCp Eq ETF | 0.15% | 43K | $143,734 | — | September 30, 2026 |
| 14 | Fidelity Total Market Index | 0.14% | 39K | $130,415 | +11,860 (+44.0%) | August 31, 2026 |
| 15 | Nuveen Small Cap Blend Idx R6 | 0.12% | 33K | $111,078 | — | August 31, 2026 |
| 16 | Fidelity Series Total Market Index | 0.11% | 32K | $105,968 | — | August 31, 2026 |
| 17 | EQ/2000 Managed Volatility IB | 0.10% | 27K | $89,134 | — | August 31, 2026 |
| 18 | iShares Russell 2000 Value ETF | 0.09% | 24K | $79,797 | +36 (+0.2%) | September 30, 2026 |
| 19 | Vanguard Russell 2000 Growth ETF | 0.08% | 23K | $78,419 | −1 (−0.0%) | September 30, 2026 |
| 20 | Fidelity Small Cap Growth Index | 0.08% | 23K | $76,816 | +2,830 (+14.1%) | July 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
UNCY insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2022-05-16 | Brigitte Schiller | Buy | $0.82 | 15,000 | $12,300 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
UNCY shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns UNCY
Institutional investors own 42.5% of Unicycive Therapeutics's shares and insiders 2.26%. The largest holder is Nantahala Capital Management, LLC with 10.06% of the shares (2.8M), as of June 30, 2026. Among the top 20 institutions, 15 added shares and 3 reduced their stake in the latest filings. Short interest is 17.83% of the float, or 5.57 days of average trading volume. The share count rose 1,205.0% since 2019.
Related: UNCY analyst forecast, UNCY key metrics. See the UNCY stock overview for the latest quote and news.
UNCY ownership FAQ
Who owns the most Unicycive Therapeutics stock?
The largest shareholders of Unicycive Therapeutics are Nantahala Capital Management, LLC (10.06%), BlackRock Inc (5.07%), Vanguard Capital Management, LLC (3.85%), Octagon Capital Advisors LP (3.59%), Geode Capital Management, LLC (2.02%).
What percentage of Unicycive Therapeutics is owned by institutions?
Institutions hold 42.5% of Unicycive Therapeutics's shares outstanding; insiders hold 2.26%.
Which funds own Unicycive Therapeutics?
The largest fund holders of Unicycive Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (2.89%), iShares Russell 2000 ETF (2.22%), Fidelity Small Cap Index (0.97%), iShares Russell 2000 Growth ETF (0.73%), PPF Helix Biotechnology I USD (0.57%).
What is Unicycive Therapeutics's short interest?
4.9M shares of Unicycive Therapeutics were sold short, 17.83% of the float; at the average daily volume it would take 5.57 days to cover.
Are insiders buying or selling Unicycive Therapeutics?
Of the latest 1 reported insider transactions in Unicycive Therapeutics (since May 16, 2022), 1 were purchases and 0 were sales.
How many shares of Unicycive Therapeutics are outstanding?
Unicycive Therapeutics has 27.4M shares outstanding, of which 27.2M are in the public float.